TH17- and IL-17- mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia

Minerva Ginecologica

Volumn 66, Issue 3, 2014, Pages 243-249

  Cornelius, D C ^a   Lamarca, B ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Hypertension; Pre eclampsia; Pregnancy

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 17;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL MIGRATION; CYTOKINE PRODUCTION; HUMAN; HYPERTENSION; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INTRAUTERINE PRESSURE; LYMPHOCYTE FUNCTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; PROTEIN EXPRESSION; REVIEW; TH17 CELL; UTERUS BLOOD FLOW; ANIMAL; FEMALE; IMMUNOLOGY; METABOLISM;

ANIMALS; AUTOANTIBODIES; FEMALE; HUMANS; INTERLEUKIN-17; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TH17 CELLS;

EID: 84904106388     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. von Vietinghoff S, Ley K. Interleukin 17 in vascular inflammation. Cytokine & Growth Factor Reviews 2010;21:463-9.
2. Gaffen SL. An overview of IL-17 function and signaling. Cytokine 2008;43:402-7.
3. Novotny SR, Wallace K, Heath J, Moseley J, Dhillon P, Weimer A et al. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. Am J Physiol Regul Integr Comp Physiol 2012;302:R1197-201.
4. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995;3:811-21. (Pubitemid 26091152)
5. Tam Tam KB, Lamarca B, Arany M, Cockrell K, Fournier L, Murphy S et al. Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. Am J Hypertens 2011;24:110-3.
6. Parrish MR, Wallace K, Tam Tam KB, Herse F, Weimer A, Wenzel K et al. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension. Am J Hypertens 2011;24:835-40.
7. Siddiqui LA, Jaleel A, Tamimi W, Al Kadri HM. Role of oxidative stress in the pathogenesis of pre-eclampsia. Arch Gynecol Obstet 2010;282:469-74.
8. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012;181:8-18.
9. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485-517.
10. Wallace K, Novotny S, Heath J, Moseley J, Martin JN Jr, Owens MY et al. Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol 2012;303:R144-9.
11. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995;155:5483-6.
12. Cornelius DC, Hogg JP, Scott J, Wallace K, Herse F, Moseley J et al. Administration of Interleukin-17 Soluble Receptor C Suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy. Hypertension 2013;62:1068-73.
13. Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 2005;1:98-114; quiz 20.
14. Schiffrin EL. The immune system: role in hypertension. Can J Cardiol 2013;29:543-8.
15. Singleton PA, Mirzapoiazova T, Guo Y, Sammani S, Mambetsariev N, Lennon FE et al. High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness. Am J Physiol Lung Cell Mol Physiol 2010;299:L639-51.
16. Weis SM. Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 2008;15:243-9. (Pubitemid 351509347)
17. George EM, Granger JP. Recent insights into the pathophysiology of pre-eclampsia. Expert review of Obstetrics & Gynecology 2010;5:557-66.
18. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996;183:2593-603. (Pubitemid 26193037)
19. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010;55:500-7.
20. Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T, Saito S. Circulating and decidual Th17 cell levels in healthy pregnancy. Am J Reprod Immunol 2010;63:104-9.
21. Saito S, Nakashima A, Ito M, Shima T. Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology. Expert Rev Clin Immunol 2011;7:649-57.
22. Pongcharoen S, Somran J, Sritippayawan S, Niumsup P, Chanchan P, Butkhamchot P et al. Interleukin-17 expression in the human placenta. Placenta 2007;28:59-63. (Pubitemid 44734617)
23. Ostojic S, Dubanchet S, Chaouat G, Abdelkarim M, Truyens C, Capron F. Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy. Am J Reprod Immunol 2003;49:101-12. (Pubitemid 36612055)
24. Pongcharoen S, Niumsup P, Sanguansermsri D, Supalap K, Butkhamchot P. The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells. Am J Reprod Immunol 2006;55:291-300. (Pubitemid 43349265)
25. Pongcharoen S, Supalap K. Interleukin-17 increased progesterone secretion by JEG-3 human choriocarcinoma cells. Am J Reprod Immunol 2009;61:261-4.
26. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in pre-eclampsia. J Immunol 2009;183:7023-30.
27. Martinez-Garcia EA, Chavez-Robles B, Sanchez-Hernandez PE, Nunez-Atahualpa L, Martin-Maquez BT, Munoz-Gomez A et al. IL-17 increased in the third trimester in healthy women with term labor. Am J Reprod Immunol 2011;65:99-103.
28. Saito S. Th17 cells and regulatory T cells: new light on pathophysiology of pre-eclampsia. Immunol Cell Biol 2010;88:615-7.
29. Toldi G, Rigo J Jr, Stenczer B, Vasarhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol 2011;66:223-9.
30. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in pre-eclampsia. J Reprod Immunol 2012;93:75-81.
31. Ozkan ZS, Simsek M, Ilhan F, Deveci D, Godekmerdan A, Sapmaz E. Plasma IL-17, IL-35, interferon-gamma, SOCS3 and TGF-beta levels in pregnant women with pre-eclampsia, and their relation with severity of disease. J Matern Fetal Neonatal Med 2013 [Epub ahead of print].
32. Jianjun Z, Yali H, Zhiqun W, Mingming Z, Xia Z. Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia. Am J Reprod Immunol 2010;63:38-45.
33. Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M et al. Angiogenic biomarkers for prediction of early pre-eclampsia onset in high-risk women. J Matern Fetal Neonatal Med 2013 [Epub ahead of print].
34. Gluchowska M, Kowalska-Koprek U, Karowicz-Bilinska A. [Evaluation of the usefulness of endoglin level as a predictor of pre-eclampsia in pregnant women with hypertension]. Ginekologia polska 2013;84:835-40.
35. Szpera-Gozdziewicz A, Breborowicz GH. Endothelial dysfunction in the pathogenesis of pre-eclampsia. Front Biosci 2014;19:734-46.
36. Dhillion P, Wallace K, Herse F, Scott J, Wallukat G, Heath J et al. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol 2012;303:R353-8.
37. Cornelius DC, Wallace K, Kipprono L, Dhillion P, Moseley J, Lamarca B. Endothelin-1 is not a Mechanism of IL-17 Induced Hypertension during Pregnancy. Medical Journal of Obstetrics and Gynecology 2013;1:1006.
38. Li J, LaMarca B, Reckelhoff JF. A model of pre-eclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol 2012;303:H1-8.
39. Schiffrin EL. Immune mechanisms in hypertension and vascular injury. Clin Sci (Lond) 2014;126:267-74.
40. LaMarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology (Bethesda) 2013;28:225-33.
41. Brewster JA, Orsi NM, Gopichandran N, Ekbote UV, Cadogan E, Walker JJ. Host inflammatory response profiling in pre-eclampsia using an in vitro whole blood stimulation model. Hypertension in Pregnancy 2008;27:1-16. (Pubitemid 351302215)
42. Wallace K, Richards S, Dhillon P, Weimer A, Edholm ES, Bengten E et al. CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy. Hypertension 2011;57:949-55.